Please assess the completion status of the following clinical trial:

Trial Title: A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has a documented clinical history of seasonal allergic rhinitis symptoms that become worse during the study season~* Patient is a non-smoker~* Patient is in good mental and physical health~Exclusion Criteria:~* Patient is hospitalized~* Patient is a woman who is \<8 weeks postpartum or is breast feeding~* Patient intends to move or vacation away during the study~* Patient is a current or past abuser of alcohol or illicit drugs

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): montelukast
- 2 (Type: ACTIVE_COMPARATOR): loratadine
- 3 (Type: PLACEBO_COMPARATOR): placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).